Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > New Press Release - Theratechnologies Announces Agreement in Principle with Marathon to Amend Some of the Terms and Conditions of its Loan Facility

<< Previous

Bullboard Posts

Next >>

Comment by palinc2000on Sep 25, 2023 10:58am

69 Views

Post# 35652174

RE:RE:RE:RE:New Press Release - Theratechnologies Announces Agreement in Principle with Marathon to Amend Some of the Terms and Conditions of its Loan Facility

PEACE NOT PIECE

palinc2000 wrote: It gives piece of mind to have Marathon pull the plug in the short term..Its gives more time for a turnaround ...Its a relief with a cost ,,,of a badly negotiated deal from the start

Kd5513 wrote:
Am I reading correctly.....

Marathon cost of warrant is now 60% less than before and we get only needing 15 million in cash? Also we pay them 600k for this? Not seeing this as a huge win am I wrong?